Does it seem coincidental that the $90k/yr Avastin was deemed ineffectural by the FDA as Obamacare ramps up?

Doctors and patients say it is effective. Private insurance companies have been covering it. It is for women with breast cancer that don't respond to other treatments and are going to die. So, is this just pure coincidence?